Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT‐AF

Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT‐AF

Background Oral anticoagulation (OAC) reduces stroke risk in atrial fibrillation, but bleeding is a frequent side effect. The decision to discontinue or modify medication regimens in response to a bleeding event may differ according to bleeding site and severity. Methods and Results We used data fro...

Full description

Bibliographic Details
Main Authors: Emily C. O'Brien, DaJuanicia N. Holmes, Laine Thomas, Gregg C. Fonarow, Peter R. Kowey, Jack E. Ansell, Kenneth W. Mahaffey, Bernard J. Gersh, Eric D. Peterson, Jonathan P. Piccini, Elaine M. Hylek
Format: Article
Language:English
Published: Wiley 2018-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
anticoagulation
atrial fibrillation
bleeding
risk stratification
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.006391

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.006391

Similar Items